Skip to main content
. Author manuscript; available in PMC: 2021 Jul 10.
Published in final edited form as: J Control Release. 2020 Apr 23;323:293–310. doi: 10.1016/j.jconrel.2020.04.032

Figure 9. Comparison of drug exposure in the metabolizing organs (liver and kidney) of mice orally administrated with free-6-S and 6-S-NL.

Figure 9.

(A) AUC of M2 in the liver and kidney tissues after oral delivery of free-6-S, 6-S-NL to mice. (n=3) (B) AUC of M13 in the liver and kidney tissues. (n=3) (C) Percentages of 6-shogaol, M2, and M13 in the liver and kidney tissues of free-6-S and 6-S-NL treated mice. (Average, n=3) (*P < 0.05, **P < 0.01, ***P < 0.001, ND: not detected)